Cargando…

Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0

BACKGROUND: The Aptima HCV Quant Dx assay (Aptima assay) is a fully automated quantitative assay on the Panther® system. This assay is intended for confirmation of diagnosis and monitoring of HCV RNA in plasma and serum specimens. The purpose of the testing described in this paper was to evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Worlock, A., Blair, D., Hunsicker, M., Le-Nguyen, T., Motta, C., Nguyen, C., Papachristou, E., Pham, J., Williams, A., Vi, M., Vinluan, B., Hatzakis, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379753/ https://www.ncbi.nlm.nih.gov/pubmed/28372576 http://dx.doi.org/10.1186/s12985-017-0727-3

Ejemplares similares

Performance evaluation of the DAAN HCV assay for quantification of hepatitis C virus RNA and its comparison with COBAS AmpliPrep/COBAS TaqMan HCV Quantitative Test, v2.0
por: He, Yuting, et al.
Publicado: (2020)

Analytical characteristics and comparative evaluation of Aptima HIV-1 Quant Dx assay with Ampliprep/COBAS TaqMan HIV-1 test v2.0
por: Hatzakis, Angelos., et al.
Publicado: (2016)

Evaluation of the Upgraded Version 2.0 of the Roche COBAS(®) AmpliPrep/COBAS(®) TaqMan HIV-1 Qualitative Assay in Central African Children
por: Mossoro-Kpinde, CD, et al.
Publicado: (2016)

Comparison of the QIAGEN artus HBV QS-RGQ Assay With the Roche COBAS AmpliPrep/COBAS TaqMan HBV Assay for Quantifying Viral DNA in Sera of Chronic Hepatitis B Patients
por: Han, Mi-Soon, et al.
Publicado: (2017)

Comparison of Amplix® hepatitis B virus and Roche COBAS AmpliPrep/COBAS Taqman hepatitis B virus assay in quantifying HBV DNA in plasma of chronic hepatitis B in Senegal
por: Lô, Gora, et al.
Publicado: (2021)

Comparison of the Aptima HIV‐1 Quant Dx assay with the COBAS AmpliPrep/COBAS TaqMan HIV‐1 v2.0 Test for HIV‐1 viral load quantification in plasma samples from HIV‐1–infected patients
por: Longo, Serena, et al.
Publicado: (2018)

Performance Evaluation of the Aptima Assays in Comparison with the cobas 6800 Assays for the Detection of HIV-1, HBV, and HCV in Clinical Samples
por: Park, Younhee, et al.
Publicado: (2022)

Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in Kenya
por: Zeh, Clement, et al.
Publicado: (2017)

Performance of the New Aptima HCV Quant Dx Assay in Comparison to the Cobas TaqMan HCV2 Test for Use with the High Pure System in Detection and Quantification of Hepatitis C Virus RNA in Plasma or Serum
por: Schalasta, Gunnar, et al.
Publicado: (2016)

Multicenter Evaluation of Two Next-Generation HIV-1 Quantitation Assays, Aptima Quant Dx and Cobas 6800, in Comparison to the RealTime HIV-1 Reference Assay
por: Wiesmann, Frank, et al.
Publicado: (2018)

Cobas Ampliprep/Cobas TaqMan HIV-1 v2.0 Assay: Consequences at the Cohort Level
por: Taylor, Ninon, et al.
Publicado: (2013)

Evaluation of the Aptima HBV Quant Assay Compared to Abbott RealTime M2000 HBV Quant Assay and Procleix Ultrio Plus dHBV Assay in Plasma Samples
por: Yan, Ying, et al.
Publicado: (2022)

American ginseng (Panax quinquefolius) administration does not affect performance of the Roche COBAS Ampliprep/Taqman HIV-1 RNA assay
por: Bakshi, Rahul P, et al.
Publicado: (2014)

An in-house real-time polymerase chain reaction: standardisation and comparison with the Cobas Amplicor HBV monitor and Cobas AmpliPrep/Cobas TaqMan HBV tests for the quantification of hepatitis B virus DNA
por: Santos, Ana Paula de Torres, et al.
Publicado: (2016)

Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test
por: Mokhtari, Camelia, et al.
Publicado: (2016)

Improved assay protocol for measurement of ammonia on the Roche Cobas 8000 automated platform
por: Kaplon, J., et al.
Publicado: (2018)

Performance of 6 routine coagulation assays on the new Roche Cobas t711 analyzer
por: Oostendorp, Marlies, et al.
Publicado: (2019)

Comparison of the performance of Aptima HIV-1 Quant Dx Assay with Abbott RealTime HIV Assay for viral load monitoring using plasma and Dried Blood Spots collected in Kenya
por: Mwau, Matilu, et al.
Publicado: (2022)

Measuring plasma ferritin levels with two different methods: A comparison of Roche Cobas e601 versus Roche Cobas c501 (integrated modular system Roche Cobas 6000)
por: Ayan, Durmuş, et al.
Publicado: (2020)

Traceability, reproducibility and clinical evaluation of Sansure Realtime HCV RNA assay
por: Huang, Xiangbo, et al.
Publicado: (2016)

Multisite Performance Evaluation of the cobas 5800 System and Comparison to the cobas 6800/8800 Systems for Quantitative Measurement of HBV, HCV, and HIV-1 Viral Load
por: Tschäpe, Jakob, et al.
Publicado: (2022)

Comparison of the COBAS/Ampliprep Taqman and Amplicor HIV-1 monitor tests in Lagos, Nigeria
por: Amoo, Olufemi S., et al.
Publicado: (2013)

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study
por: Preisler, Sarah, et al.
Publicado: (2016)

Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
por: Smithgall, Marie C., et al.
Publicado: (2020)

Evaluation of the Aptima(®) HIV‐1 Quant Dx assay for HIV‐1 RNA viral load detection and quantitation in plasma of HIV‐1‐infected individuals: A comparison with Abbott RealTime HIV‐1 assay
por: Amendola, Alessandra, et al.
Publicado: (2016)

Evaluation of the Roche cobas MTB and MTB-RIF/INH Assays in Samples from Germany and Sierra Leone
por: Nadarajan, Darshaalini, et al.
Publicado: (2021)

Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy
por: Mücke, Marcus M., et al.
Publicado: (2019)

The cobas(®) HCV GT is a new tool that accurately identifies Hepatitis C virus genotypes for clinical practice
por: Fernández-Caballero, J. A., et al.
Publicado: (2017)

Internal quality assurance of HIL indices on Roche Cobas c702
por: Lippi, Giuseppe, et al.
Publicado: (2018)

Evaluation of the Abbott Real Time HCV genotype II assay for Hepatitis C virus genotyping
por: Sariguzel, Fatma Mutlu, et al.
Publicado: (2015)

Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples
por: Bell, Margo, et al.
Publicado: (2023)

Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment
por: Ogawa, Eiichi, et al.
Publicado: (2010)

Evaluation of electrochemiluminescence immunoassays for immunosuppressive drugs on the Roche cobas e411 analyzer
por: Fung, Angela W.S., et al.
Publicado: (2017)

Soluble Transferrin Receptor during infancy and reference intervals for the Roche Cobas platform
por: Larsson, Sara Marie, et al.
Publicado: (2020)

Androgens in women: Establishing reference intervals for dehydroepiandrostenedione sulphate and androstenedione on the Roche Cobas
por: Bokulić, Adriana, et al.
Publicado: (2023)

Comparison of Roche TaqMan v.2.0, Abbott RealTime and Modified Abbott Residual Viremia Assays in Testing of Routine Samples for Viremia Monitoring in HIV Care
por: Mckinnon, John, et al.
Publicado: (2017)

Equivalent Performance of the Cobas(®) Cdiff Test for Use on the Cobas(®) Liat(®) System and the Cobas(®) 4800 System
por: Garg, Sachin K, et al.
Publicado: (2017)

Detection of SARS-CoV-2 infection in asymptomatic populations using the DiaSorin molecular Simplexa and Roche Cobas EUA assays
por: Antonara, Stella, et al.
Publicado: (2022)

Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays
por: Lau, C.S., et al.
Publicado: (2021)

Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment
por: Wiesmann, F., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sjtu75p1gqs0p2nmfbn501t9ej